The latest biotech news

treefrog therapeutics cell therapy parkinsons disease

News and Trends 13 May 2019

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

The French company Treefrog Therapeutics has raised over €7M in Series A investment to develop its encapsulation technology to improve the production of stem cells for cell therapies. Part of the Series A money will help Treefrog to automate its stem cell production process by 2021. The round will also fund the development of a […]

May 13, 2019 - 3 minutesmins - By Jonathan Smith

pneumonia lungs polyphor antibiotic resistance

News and Trends 10 May 2019

Swiss Biotech Halts Pneumonia Antibiotic Trial After Patient Safety Scare

Polyphor has temporarily halted two phase III trials of an antibiotic treating pneumonia, after an unexpectedly high number of patients reported kidney problems in one of the trials. The phase III trial was testing the antibiotic murepavadin in 150 enrolled patients with hospital-acquired pneumonia, and who required mechanical breathing. The patients in the treatment group […]

May 10, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 8 May 2019

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia on single cells from a patient’s blood sample, which could speed up drug discovery and help to personalize treatments for people with the condition. Around 21 million people worldwide suffer from schizophrenia, and this is likely to get worse with […]

May 8, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 7 May 2019

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Confo Therapeutics has raised €30M in a Series A round that will take its unique technology to find drugs for historically undruggable targets to clinical trials. The fundraising was led by the VCs BioGeneration Ventures and Wellington Partners, and joined by several other private and public investors. With the money, Confo Therapeutics aims to […]

May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

bees dying university of Cambridge vaccine virus

News and Trends 6 May 2019

Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations

A research team has discovered that honeybees pass molecules of RNA to each other by sharing it in edible jelly, which could lead to vaccines that can stop generations of bees from dying from viral infections. Honeybees don’t just give us honey. As the dominant pollinators of lots of food crops, around a third of […]

May 6, 2019 - 2 minutesmins - By Jonathan Smith

combioxin antibiotic resistance pneumonia

News and Trends 3 May 2019

Drug Mopping Up Bacterial Toxins Shows Potential to Tackle Antibiotic Resistance in Phase I

An antibiotic-enhancing drug developed by the Swiss biotech Combioxin to tackle antibiotic resistance showed promising effects in a phase I trial. Antibiotic resistance is a growing problem around the world, causing common infections such as pneumonia to become harder to treat. As standard antibiotics become less and less effective, we urgently need to find new […]

May 3, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 2 May 2019

Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients

Developed by the French biotech Genkyotex, a first-in-class treatment for the liver disease primary biliary cholangitis failed to reduce a key disease biomarker in a phase II trial, but showed potential for reducing liver scarring. Primary biliary cholangitis is an autoimmune disease that damages the liver and can lead to liver scarring (fibrosis) or the […]

May 2, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 1 May 2019

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

Cambridge-based Congenica has closed a €27M (£23.3M) series B fundraising round to support the use of its rare disease diagnostics platform by the newly formed NHS Genomic Medicine Service, as well as to allow the company to expand internationally. The genomics diagnostic company received a €15.5M (£13.3M) investment, led by the London-based fund management firm […]

May 1, 2019 - 2 minutesmins - By Helen Albert

News and Trends 1 May 2019

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

Cell Medica’s next-generation CAR-T cell therapy has resulted in ‘extensive tumor regression’ in a child with high-risk neuroblastoma, one of the deadliest types of childhood cancer. Only available to cancer patients for the last couple of years, CAR-T cell therapy has had impressive results in treating patients for whom other available options do […]

May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Apr 2019

Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia

Patients with the life-threatening blood disorder beta-thalassemia required fewer blood transfusions after receiving a gene therapy developed by the UK company Orchard Therapeutics, with four out of nine no longer depending on transfusions. Beta thalassemia is a genetic disorder that affects hemoglobin, a protein that blood cells use to carry oxygen. In the most severe […]

April 30, 2019 - 3 minutesmins - By Jonathan Smith

liver fibrosis alentis switzerland cirrhosis cancer

News and Trends 30 Apr 2019

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Founded in March this year, Alentis Therapeutics has bagged a Series A round of €11.1M (CHF 12.5M) to develop antibody drugs treating liver fibrosis, which currently has no approved treatments. Liver fibrosis is the scarring of liver tissue, which can happen as a consequence of aging, chronic hepatitis or conditions such as non-alcoholic steatohepatitis (NASH). […]

April 30, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 30 Apr 2019

Cosmetics Giant Acquires German Biotech’s Spider Silk Cosmetics Arm

The Swiss Givaudan, one of the largest cosmetics, flavors and fragrances companies in the world, has acquired the cosmetics business of AMSilk, a biotech company that uses genetic engineering to produce spider silk proteins in bacteria. Silk is a valuable material in the cosmetics industry, used to offer protection against pollution and keep cosmetic […]

April 30, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks

Swiss Biotech Halts Pneumonia Antibiotic Trial After Patient Safety Scare

Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations

Drug Mopping Up Bacterial Toxins Shows Potential to Tackle Antibiotic Resistance in Phase I

Drug for Autoimmune Liver Disease Yields Mixed Results in Hard-to-Treat Patients

UK Genome Diagnostics Biotech Closes €27M Series B to Support NHS

Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma

Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia

Swiss Biotech Raises €11M to Develop Treatments for Liver Fibrosis

Cosmetics Giant Acquires German Biotech’s Spider Silk Cosmetics Arm

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!